10.01.10
San Clemente, CA-based Metagenics, Inc. has acquired Catalina Lifesciences, Irvine, CA, which makes Bariatric Advantage, a micronutrient replacement product for surgical weight loss patients. Terms of the acquisition were not disclosed. Currently, 10 million people in the U.S. have a body mass index (BMI) measurement of 35 or higher and co-morbid health conditions that make them candidates for weight loss surgery. Each year, approximately 230,000 individuals have weight loss surgery in the U.S. alone. Bariatric Advantage products provide these individuals with absorbable nutrients to promote long-term health following their surgery. Each Bariatric Advantage product meets Metagenics’ manufacturing standards and is formulated to promote ease of absorption, good taste and long-term patient compliance.